Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

4D Molecular Therapeutics Q3 EPS $(0.79) Up From $(0.82) YoY

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.79) per share. This is a 3.66 percent increase over losses of $(0.82) per share from the same period last year.
byBill Haddad
November 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.79) per share. This is a 3.66 percent increase over losses of $(0.82) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts